Flow Pharma
East Palo Alto, CA
Flow Pharma offers a T-Cell based vaccine delivery platform. The vaccine platform has been tested in an HIV vaccine application (Immunity Project program in partnership with Until There’s A Cure) yielding promising results in animals and in human blood. Flow Pharma is now using a similar approach to develop a vaccine for Ebola, Marburg, and triple negative breast cancer. The company received the first breast cancer collaboration agreement at the largest cancer hospital in Saudi Arabia on 5/11/23. Flow Pharma has 10 issued patents in the US, EU, Canada and Australia and 10 published scientific articles can be found here www.flowpharma.com We are based in Cleveland, Ohio and Riyadh, Saudi Arabia.
flowpharma.comEmploybl Premium
Get the inside track on Flow Pharma
Premium profiles, AI research on tech stack and hiring, 61,000+ ATS job listings, saved searches, and an AI chat that knows the SF startup scene.
- AI chat about Flow Pharma's culture, stack, and interview process
- Save jobs and get alerts on new openings
- Full premium profiles across our company index
- 7-day free trial, then $25/mo. Cancel anytime.
Company Details
Founded
- 1999
Employees
- Between 5 - 20 employees
Raised
- $25,554,710
Headquarters Location
- East Palo Alto, CA
Public
- No
Acquired
- No
CEO
Reid Rubsamen
Founders
- Reid Rubsamen
Company Collections
These are collections Flow Pharma is a part of. Click on the collection name to view similar companies.
Flow Pharma's Industries
Flow Pharma Headquarters Location
Total Amount Raised: $25,554,710
Flow Pharma Funding Rounds
Series Unknown
$225,000
Series Unknown
$225,000
Series Unknown
$180,000
Series Unknown
$180,000
Series A
$24,000,000
Series A
$24,000,000
Series Unknown
$1,149,710
Series Unknown
$1,149,710
Flow Pharma Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Flow Pharma.